Issues in biochemical applications to risk assessment: when can lymphocytes be used as surrogate markers?
Lucier
G W
GW
Laboratory of Biochemical Risk Analysis, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.
Thompson
C L
CL
D014408:Biomarkers, Tumor / Q000032:analysis*; D002273:Carcinogens / Q000633:toxicity*; D003582:Cytogenetics; D004249:DNA Damage; D004260:DNA Repair / Q000187:drug effects; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D009153:Mutagens / Q000032:analysis; D009154:Mutation; D011506:Proteins / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000187:drug effects; D012306:Risk
D014408:Biomarkers, Tumor; D002273:Carcinogens; D009153:Mutagens; D011506:Proteins; D011956:Receptors, Cell Surface